Login / Signup
Potential of muvalaplin as a lipoprotein(a) inhibitor.
Amanda J Hooper
P Mihika S Fernando
John R Burnett
Published in:
Expert opinion on investigational drugs (2024)
Keyphrases
</>
human health
low density lipoprotein
risk assessment